trending Market Intelligence /marketintelligence/en/news-insights/trending/iq94afj0dpt1tst6dzl1la2 content esgSubNav
In This List

Addex raises CHF40M via capital offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Addex raises CHF40M via capital offering

Geneva-based Addex Therapeutics Ltd. completed a CHF40 million capital offering.

The company issued 13,037,577 new shares at CHF3.13 apiece.

Addex intends to use the proceeds to develop its portfolio of drug candidates, including registration studies for lead program dipraglurant, a treatment for Parkinson's disease.